The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 11, 2011, Pages 1106-1111

  Zhang, Irene ^a   Branstetter IV, Barton F ^a,b   Beswick, Daniel M ^b   Maxwell, Jessica H ^a   Gooding, William E ^c   Ferris, Robert L ^a,c  

^a University of Pittsburgh School of Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOVERSOL; LSO ALLEGRA; LUTETIUM OXYORTHOSILICATE; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CANCER SURVIVAL; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VIRUS CARCINOGENESIS; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IN SITU HYBRIDIZATION; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; PENNSYLVANIA; POPULATION SURVEILLANCE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 81855168363     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.181     Document Type: Article

References (21)

1. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571-578.
2. Leemans CR, Tiwari R, Nauta JJP, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73(1):187-190. (Pubitemid 24012742)
3. Ritoe SC, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA. Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer. 2004;101(6):1382-1389. (Pubitemid 39180394)
4. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxy- glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer. Head Neck. 2001;23(11):933-941. (Pubitemid 32977535)
5. Yao M, Smith RB, Graham MM, et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys. 2005;63(4):991-999. (Pubitemid 41505274)
6. Nayak JV, Walvekar RR, Andrade RS, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PTE-CT. Laryngoscope. 2007;117(12):2129-2134. (Pubitemid 351339585)
7. Andrade RS, Heron DE, Degirmenci B, et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65(5):1315-1322. (Pubitemid 44425218)
8. Branstetter BF IV, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology. 2005;235(2):580-586. (Pubitemid 40571100)
9. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261-269. (Pubitemid 351480538)
10. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-720. (Pubitemid 30365531)
11. Gillison MJ, Westra W, Chung C, et al. Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer in RTOG 0129 [abstract 6003]. American Society of Clinical Oncology Web site. http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst-detail- view&confID= 65&abstractID=31969. Accessed July 13, 2011.
12. Moeller BJ, Rana V, Cannon BA, et al. Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009;27(15):2509-2515.
13. Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res. 2003;9(17):6469-6475. (Pubitemid 38031835)
14. Bickel P, Doksum K. Mathematical Statistics Basic Ideas and Selected Topics. Oakland, CA: Holden-Day; 1977:177-182.
15. Rabalais AG, Walvekar R, Nuss D, et al. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy. Laryngoscope. 2009;119(6):1120-1124.
16. Passero VA, Branstetter BF, Shuai Y, et al. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol. 2010;21(11):2278-2283.
17. Wang YF, Liu RS, Chu PY, et al. Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy. Head Neck. 2009;31(4):442-451.
18. Abgral R, Querellou S, Potard G, et al. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med. 2009;50(1):24-29.
19. Yao M, Smith RB, Hoffman H, et al. Clinical significance of postradiotherapy 18F-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer - a long-term outcome report. Int J Radiat Oncol Biol Phys. 2009;74(1):9-14.
20. NCCN clinical practice guidelines in oncology: head and neck cancers. National Comprehensive Cancer Network Web site. http://www.nccn.org/ professionals/physician-gls/pdf/head-and-neck.pdf. Accessed September 20, 2011.
21. Gourin CG, Williams HT, Seabolt WN, Herdman AV, Howington JW, Terris DJ. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope. 2006;116(5):705-710. (Pubitemid 44318024)